HK inno.N Corporation
195940 | KO
Overview
Corporate Details
- ISIN(s):
- KR7195940002
- LEI:
- Country:
- South Korea
- Address:
- 충청북도 청주시 흥덕구 오송읍 오송생명2로 239 에이치케이이노엔(주) 오송공장, 청주시
- Website:
- https://www.inno-n.com/eng
- Sector:
- Manufacturing
- Industry:
- Manufacture of pharmaceuticals, medicinal chemical and botanical products
Description
No description available.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
You have of free filing views remaining.
Upgrade for unlimited access.
Bulk Actions:
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2025-08-14 00:00 |
Interim / Quarterly Report
반기보고서 (2025.06)
|
Korean | 1.5 MB | ||
| 2025-07-30 00:00 |
Report Publication Announcement
기업설명회(IR)개최
|
Korean | 6.6 KB | ||
| 2025-07-30 00:00 |
Report Publication Announcement
기업설명회(IR)개최
|
Korean | 6.7 KB | ||
| 2025-07-30 00:00 |
Earnings Release
영업(잠정)실적(공정공시)
|
Korean | 14.4 KB | ||
| 2025-07-24 00:00 |
Report Publication Announcement
결산실적공시예고
|
Korean | 4.1 KB | ||
| 2025-06-30 00:00 |
Environmental & Social Information
지속가능경영보고서등관련사항(자율공시)
|
Korean | 10.6 KB | ||
| 2025-06-19 00:00 |
Report Publication Announcement
기업설명회(IR)개최
|
Korean | 6.6 KB | ||
| 2025-05-15 00:00 |
Quarterly Report
분기보고서 (2025.03)
|
Korean | 1.3 MB | ||
| 2025-05-07 00:00 |
Regulatory Filings
투자판단관련주요경영사항(임상시험계획승인신청등결정) (IN-B00009의 제3상 임상시험계획 승인)
|
Korean | 10.7 KB | ||
| 2025-04-30 00:00 |
Regulatory Filings
소속부변경
|
Korean | 3.6 KB | ||
| 2025-04-28 00:00 |
Earnings Release
영업(잠정)실적(공정공시)
|
Korean | 14.4 KB | ||
| 2025-04-28 00:00 |
Report Publication Announcement
기업설명회(IR)개최
|
Korean | 6.6 KB | ||
| 2025-04-28 00:00 |
Report Publication Announcement
기업설명회(IR)개최
|
Korean | 6.6 KB | ||
| 2025-04-22 00:00 |
Report Publication Announcement
결산실적공시예고
|
Korean | 4.1 KB | ||
| 2025-03-26 00:00 |
AGM Information
정기주주총회결과
|
Korean | 20.7 KB |
Automate Your Workflow. Get a real-time feed of all HK inno.N Corporation filings delivered via API.
Market Data
Market Data Not Available
Last Price
Change / %
Market Cap
N/A
Volume
Day High
Day Low
52W High
52W Low
Financials & KPIs
No data available
Unlock Full Financials for HK inno.N Corporation
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for HK inno.N Corporation via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
Company
Country
Ticker
View
Develops and commercializes small-molecule medicines for CNS, cardiovascular, and immune disorders.
Switzerland
IDIA
Switzerland
IDIA
Develops & manufactures pharmaceuticals, APIs, and offers CMO services for various diseases.
South Korea
249420
South Korea
249420
Develops pharmaceuticals like antibiotics and anesthetics, expanding into CNS and GI therapies.
South Korea
003120
South Korea
003120
Develops & manufactures drugs, vaccines & supplements for oncology & gastroenterology needs.
South Korea
007570
South Korea
007570
A clinical-stage biopharma developing immuno-oncology agents and bispecific antibodies for cancer.
United States of America
IMAB
United States of America
IMAB
A clinical-stage biopharma pioneering therapies for immune & inflammatory diseases.
United States of America
IMA
United States of America
IMA
Develops a drug delivery platform using ultrasound and nanotech for oncology.
South Korea
456570
South Korea
456570
Develops T-cell redirecting immunotherapies (ACT & TCR Bispecifics) for solid tumor cancers.
United States of America
IMTX
United States of America
IMTX
Developing safer cell therapies for AL Amyloidosis and hematologic malignancies.
United States of America
IMMX
United States of America
IMMX